Drug or technology

Losartan Potassium

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

JUN 8, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Losartan Potassium 25 MG (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for labeling of a generic losartan potassium formulation; it documents a regulatory decision, not clinical trial evidence.

Regulatory UpdateStrides Pharma Losartan Potassium

Reported

Approval date2026-06-08

Application numberANDA090382

MAY 7, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Losartan Potassium (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for losartan potassium labeling; it documents a regulatory decision but does not report clinical trial outcomes or efficacy data.

Regulatory UpdateTeva Losartan Potassium